These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21842146)

  • 21. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
    Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
    Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of a high-cholesterol diet on ischemic cardiac dysfunction and remodeling induced by coronary stenosis and coronary occlusion.
    Yaoita H; Yoshinari K; Maehara K; Sando M; Watanabe K; Maruyama Y
    J Am Coll Cardiol; 2005 Jun; 45(12):2078-87. PubMed ID: 15963412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
    Stratmann B; Tschoepe D
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical significance of insulin resistance, impaired carbohydrate and lipid metabolism in the development of microcirculation pathology in patients with chronic heart failure and type 2 diabetes mellitus].
    Statsenko ME; Turkina SV; Shilina NN; Kosivtsova MA
    Klin Med (Mosk); 2016; 94(6):439-44. PubMed ID: 30289661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of late postmyocardial infarction left ventricular remodeling: an update.
    Mookadam F; Moustafa SE
    Curr Heart Fail Rep; 2009 Dec; 6(4):245-53. PubMed ID: 19948093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [From cardiovascular risk to chronic heart failure].
    Ertl G
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():17. PubMed ID: 14694837
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial repair/remodelling following infarction: roles of local factors.
    Sun Y
    Cardiovasc Res; 2009 Feb; 81(3):482-90. PubMed ID: 19050008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
    Fu F; Zhao K; Li J; Xu J; Zhang Y; Liu C; Yang W; Gao C; Li J; Zhang H; Li Y; Cui Q; Wang H; Tao L; Wang J; Quon MJ; Gao F
    Sci Rep; 2015 Dec; 5():17927. PubMed ID: 26659007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
    Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unresolved issues in left ventricular postischemic remodeling and progression to heart failure.
    Gronda E; Sacchi S; Benincasa G; Vanoli E; Napoli C
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):640-649. PubMed ID: 31343451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
    Cittadini A; Monti MG; Isgaard J; Casaburi C; Strömer H; Di Gianni A; Serpico R; Saldamarco L; Vanasia M; Saccà L
    Cardiovasc Res; 2003 Jun; 58(3):555-64. PubMed ID: 12798428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression.
    Røe ÅT; Ruud M; Espe EK; Manfra O; Longobardi S; Aronsen JM; Nordén ES; Husebye T; Kolstad TRS; Cataliotti A; Christensen G; Sejersted OM; Niederer SA; Andersen GØ; Sjaastad I; Louch WE
    Cardiovasc Res; 2019 Mar; 115(4):752-764. PubMed ID: 30351410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
    Litwin SE; Katz SE; Morgan JP; Douglas PS
    Br J Pharmacol; 1999 Aug; 127(7):1671-9. PubMed ID: 10455325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
    J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.